Remission outcomes in severe eosinophilic asthma with mepolizumab therapy: Analysis of the REDES study.
Pavord I, Gardiner F, Heaney LG, Domingo C, Price RG, Pullan A, Oppenheimer J, Brusselle G, Nagase H, Chupp G, Pizzichini E, Bañas-Conejero D, Howarth P.
Pavord I, et al. Among authors: pizzichini e.
Front Immunol. 2023 Apr 12;14:1150162. doi: 10.3389/fimmu.2023.1150162. eCollection 2023.
Front Immunol. 2023.
PMID: 37122713
Free PMC article.